Corvus: 2Q Earnings Snapshot
BURLINGAME, Calif. (AP) _ Corvus Pharmaceuticals Inc. (CRVS) on Thursday reported a loss of $11.6 million in its second quarter.
On a per-share basis, the Burlingame, California-based company said it had a loss of 40 cents.
Corvus shares have fallen 9 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $9.42, a decline of 20 percent in the last 12 months.